Evidence map›Paper›PMID 33319750›Full record

ArticleeLife2020

Downregulation of the tyrosine degradation pathway extends

Andrey A Parkhitko, Divya Ramesh, Lin Wang, Dmitry Leshchiner, Elizabeth Filine, Richard Binari, Abby L Olsen, John M Asara, Valentin Cracan, Joshua D Rabinowitz and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Methionine restriction and mimetics to ameliorate human aging and disease.Trends in endocrinology and metabolism: TEM · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Andrey A ParkhitkoDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States.ORCID 0000-0001-9852-8329
Divya RameshNational Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India.ORCID 0000-0003-1387-7832
Lin WangDepartment of Chemistry, Princeton University, Princeton, United States.ORCID 0000-0002-9370-6891
Dmitry LeshchinerDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States.
Elizabeth FilineDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States.
Richard BinariDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States.
Abby L OlsenDepartment of Neurology, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, United States.
John M AsaraDivision of Signal Transduction, Beth Israel Deaconess Medical Center, and Department of Medicine, Harvard Medical School, Boston, United States.
Valentin CracanScintillon Institute, San Diego, United States.ORCID 0000-0002-3280-0593
Joshua D RabinowitzDepartment of Chemistry, Princeton University, Princeton, United States.
Axel BrockmannNational Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India.ORCID 0000-0003-0201-9656
Norbert PerrimonDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States.ORCID 0000-0001-7542-472X
Harvard University · USHoward Hughes Medical Institute · USPrinceton University · USTata Institute of Fundamental Research · INBoston University · USBrigham and Women's Hospital · USScripps Research Institute · US

Funding

Tuberous Sclerosis-Pathway and PathogenesisP01CA120964 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI David J. Kwiatkowski · 2007 to 2026
$35.9M
Drosophila Transgenic RNAi Resource ProjectR01GM084947 · NIGMS · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2008 to 2019
$9.8M
Characterization of the Insulin to Autophagy Pathway in MusclesR01AR057352 · NIAMS · HARVARD MEDICAL SCHOOL · PI NORBERT PERRIMON · 2010 to 2026
$8.2M
Defining the genetic contribution of glia in Parkinson's disease pathogenesisK08NS109344 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OLSEN, ABBY LAUREN · 2018 to 2022
$997k
Studying methionine flux and its role in aging and neurodegenerationR00AG057792 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PARKHITKO, ANDREY A · 2020 to 2022
$871k
Engineered flavin-dependent enzymes for probing redox environment and regulationR00GM121856 · NIGMS · SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · PI CRACAN, VALENTIN · 2019 to 2021
$747k
Studying methionine flux and its role in aging and neurodegenerationK99AG057792 · NIA · HARVARD MEDICAL SCHOOL · PI PARKHITKO, ANDREY A · 2018 to 2019
$198k
National Centre for Biological Sciences 12P4167NCI NIH HHS P01 CA120964NIAMS NIH HHS R01 AR057352NIA NIH HHS K99 AG057792NIA NIH HHS R00 AG057792NIGMS NIH HHS R00 GM121856NIGMS NIH HHS R01 GM084947NINDS NIH HHS K08 NS109344NINDS NIH HHS L30 NS108208
6 · The paper itself

Abstract

Aging is characterized by extensive metabolic reprogramming. To identify metabolic pathways associated with aging, we analyzed age-dependent changes in the metabolomes of long-lived

Indexed as

AgingAnimalsDrosophila melanogasterElectron Transport Chain Complex ProteinsLongevityMitochondriaTigecyclineTyrosineTyrosine TransaminaseElectron Transport Chain Complex ProteinsTigecyclineTyrosineTyrosine TransaminaseD. melanogasterETC Complex IgeneticsgenomicsmitochondrianeurotransmittersTATtigecyclinetyrosine aminotransferase

Identifiers

PMID33319750
PMCPMC7744100
OpenAlexW3110791211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.